

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 6.26361509 |
| 2 | cytidine catabolic process (GO:0006216) | 6.26361509 |
| 3 | cytidine deamination (GO:0009972) | 6.26361509 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.71072906 |
| 5 | sequestering of actin monomers (GO:0042989) | 5.52646871 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.34830646 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 5.25267674 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.25267674 |
| 9 | DNA deamination (GO:0045006) | 5.24406556 |
| 10 | eosinophil chemotaxis (GO:0048245) | 4.98716122 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.70602802 |
| 12 | eosinophil migration (GO:0072677) | 4.47264477 |
| 13 | platelet dense granule organization (GO:0060155) | 4.42705990 |
| 14 | proteasome assembly (GO:0043248) | 4.30476558 |
| 15 | protein neddylation (GO:0045116) | 4.26593988 |
| 16 | response to gravity (GO:0009629) | 4.22329558 |
| 17 | respiratory electron transport chain (GO:0022904) | 4.17511586 |
| 18 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.15157984 |
| 19 | electron transport chain (GO:0022900) | 4.12894384 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.07397681 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.91171595 |
| 22 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.86129969 |
| 23 | positive regulation of actin filament depolymerization (GO:0030836) | 3.83507599 |
| 24 | protein complex biogenesis (GO:0070271) | 3.82660319 |
| 25 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.65203379 |
| 26 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.63683320 |
| 27 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.56198819 |
| 28 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55966082 |
| 29 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.52515918 |
| 30 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.50922034 |
| 31 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.47358929 |
| 32 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.44702725 |
| 33 | chaperone-mediated protein transport (GO:0072321) | 3.44005989 |
| 34 | GDP-mannose metabolic process (GO:0019673) | 3.42806829 |
| 35 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.42488211 |
| 36 | response to interferon-beta (GO:0035456) | 3.40320012 |
| 37 | cellular response to zinc ion (GO:0071294) | 3.39674260 |
| 38 | macrophage chemotaxis (GO:0048246) | 3.33824776 |
| 39 | negative regulation by host of viral transcription (GO:0043922) | 3.29499786 |
| 40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29360408 |
| 41 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.29247950 |
| 42 | NADH dehydrogenase complex assembly (GO:0010257) | 3.29247950 |
| 43 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.29247950 |
| 44 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.24948547 |
| 45 | post-embryonic morphogenesis (GO:0009886) | 3.24782693 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21731465 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.15333678 |
| 48 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.15155709 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 3.15155709 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.11626320 |
| 51 | establishment of viral latency (GO:0019043) | 3.09416807 |
| 52 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.09073141 |
| 53 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.05792207 |
| 54 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.00428978 |
| 55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.00157986 |
| 56 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.00157986 |
| 57 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99940052 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99940052 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99940052 |
| 60 | negative regulation of ligase activity (GO:0051352) | 2.99880725 |
| 61 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.99880725 |
| 62 | hydrogen ion transmembrane transport (GO:1902600) | 2.97506297 |
| 63 | GTP biosynthetic process (GO:0006183) | 2.96970738 |
| 64 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.95109067 |
| 65 | type B pancreatic cell proliferation (GO:0044342) | 2.94806277 |
| 66 | ATP biosynthetic process (GO:0006754) | 2.94521171 |
| 67 | metallo-sulfur cluster assembly (GO:0031163) | 2.91479342 |
| 68 | iron-sulfur cluster assembly (GO:0016226) | 2.91479342 |
| 69 | mannosylation (GO:0097502) | 2.91449663 |
| 70 | extracellular fibril organization (GO:0043206) | 2.91006768 |
| 71 | regulation of dopamine metabolic process (GO:0042053) | 2.88644392 |
| 72 | regulation of catecholamine metabolic process (GO:0042069) | 2.88644392 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86759218 |
| 74 | regulation of cellular amine metabolic process (GO:0033238) | 2.86460770 |
| 75 | dopaminergic neuron differentiation (GO:0071542) | 2.86023961 |
| 76 | proton transport (GO:0015992) | 2.85976946 |
| 77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.85705989 |
| 78 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.82762193 |
| 79 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.80800823 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.80800823 |
| 81 | hydrogen transport (GO:0006818) | 2.80575927 |
| 82 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.80033789 |
| 83 | L-fucose catabolic process (GO:0042355) | 2.79309887 |
| 84 | fucose catabolic process (GO:0019317) | 2.79309887 |
| 85 | L-fucose metabolic process (GO:0042354) | 2.79309887 |
| 86 | regulation of autophagic vacuole assembly (GO:2000785) | 2.78970802 |
| 87 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.77709304 |
| 88 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76261670 |
| 89 | actin nucleation (GO:0045010) | 2.75485063 |
| 90 | ribosomal small subunit assembly (GO:0000028) | 2.73310408 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 2.70785855 |
| 92 | establishment of integrated proviral latency (GO:0075713) | 2.67809867 |
| 93 | morphogenesis of an endothelium (GO:0003159) | 2.66533972 |
| 94 | endothelial tube morphogenesis (GO:0061154) | 2.66533972 |
| 95 | positive regulation of defense response to virus by host (GO:0002230) | 2.63064576 |
| 96 | L-ascorbic acid metabolic process (GO:0019852) | 2.61072576 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60027860 |
| 98 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.60017958 |
| 99 | negative regulation of gene silencing (GO:0060969) | 2.59930018 |
| 100 | protein targeting to mitochondrion (GO:0006626) | 2.57643671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.67859746 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.05149463 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.73526134 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.53529371 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.41614914 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.40338269 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.19521802 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.14286540 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93781443 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91013748 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.75097632 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53340786 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45582649 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34463679 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19580487 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.18369583 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.14714451 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.07434502 |
| 19 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04427771 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03126465 |
| 21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.93751023 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88392531 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.84379995 |
| 24 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.79026805 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74092640 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72671259 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66945135 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61026816 |
| 29 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.54832041 |
| 30 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.54672323 |
| 31 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.50876246 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48804462 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47736525 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47537435 |
| 35 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.45838432 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44925619 |
| 37 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.43544451 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37977082 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37535671 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37289079 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35671817 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35438421 |
| 43 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.34414891 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26985269 |
| 45 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24810862 |
| 46 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.23995457 |
| 47 | AR_20517297_ChIP-Seq_VCAP_Human | 1.23444026 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22978100 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.21133730 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20983108 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20887702 |
| 52 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18841359 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18841359 |
| 54 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16949513 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14969403 |
| 56 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.10824741 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10443025 |
| 58 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10203565 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09925173 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09904108 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05109688 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05071317 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04794504 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04709382 |
| 65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04468906 |
| 66 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.04305644 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04279178 |
| 68 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02555761 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02438807 |
| 70 | ERA_21632823_ChIP-Seq_H3396_Human | 1.01769820 |
| 71 | P300_27268052_Chip-Seq_Bcells_Human | 1.01701391 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.01074323 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99878545 |
| 74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99015045 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98688071 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97995482 |
| 77 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97830298 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96824453 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96824453 |
| 80 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.96767761 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96730532 |
| 82 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96115994 |
| 83 | CBP_21632823_ChIP-Seq_H3396_Human | 0.94929306 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94272537 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94069916 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93274721 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92943733 |
| 88 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92801091 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91746332 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.91388093 |
| 91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.90167275 |
| 92 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90035944 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89892672 |
| 94 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88959150 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88788798 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87550123 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83564759 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81932118 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81367348 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81306165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.56901006 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 3.44879674 |
| 3 | MP0004147_increased_porphyrin_level | 3.31044675 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 2.91976373 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.71998647 |
| 6 | MP0005257_abnormal_intraocular_pressure | 2.71569912 |
| 7 | MP0005360_urolithiasis | 2.63687842 |
| 8 | MP0001905_abnormal_dopamine_level | 2.44457667 |
| 9 | MP0005165_increased_susceptibility_to | 2.36508850 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.25761819 |
| 11 | MP0003011_delayed_dark_adaptation | 2.11923757 |
| 12 | MP0005387_immune_system_phenotype | 2.11686037 |
| 13 | MP0001790_abnormal_immune_system | 2.11686037 |
| 14 | MP0009785_altered_susceptibility_to | 1.94201135 |
| 15 | MP0001835_abnormal_antigen_presentation | 1.92333276 |
| 16 | MP0003638_abnormal_response/metabolism_ | 1.91974168 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.86844323 |
| 18 | MP0003075_altered_response_to | 1.82518091 |
| 19 | MP0004742_abnormal_vestibular_system | 1.77345448 |
| 20 | MP0002095_abnormal_skin_pigmentation | 1.73344918 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.69021293 |
| 22 | MP0000749_muscle_degeneration | 1.60993316 |
| 23 | MP0005025_abnormal_response_to | 1.56039668 |
| 24 | MP0005253_abnormal_eye_physiology | 1.55889718 |
| 25 | MP0000685_abnormal_immune_system | 1.54316325 |
| 26 | MP0008004_abnormal_stomach_pH | 1.53031103 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 1.51950336 |
| 28 | MP0003786_premature_aging | 1.47506694 |
| 29 | MP0003646_muscle_fatigue | 1.46582658 |
| 30 | MP0000516_abnormal_urinary_system | 1.46205038 |
| 31 | MP0005367_renal/urinary_system_phenotyp | 1.46205038 |
| 32 | MP0003866_abnormal_defecation | 1.45796274 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.45528526 |
| 34 | MP0003045_fibrosis | 1.44738601 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.43995674 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.39110825 |
| 37 | MP0009745_abnormal_behavioral_response | 1.35637796 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.34372922 |
| 39 | MP0002723_abnormal_immune_serum | 1.34028894 |
| 40 | MP0001800_abnormal_humoral_immune | 1.33933334 |
| 41 | MP0004043_abnormal_pH_regulation | 1.33468082 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.33305536 |
| 43 | MP0004510_myositis | 1.31858689 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.31172311 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.28080253 |
| 46 | MP0006082_CNS_inflammation | 1.25814636 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24868204 |
| 48 | MP0001764_abnormal_homeostasis | 1.23681338 |
| 49 | MP0001819_abnormal_immune_cell | 1.22580643 |
| 50 | MP0002102_abnormal_ear_morphology | 1.20460519 |
| 51 | MP0003186_abnormal_redox_activity | 1.20454143 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19796444 |
| 53 | MP0005083_abnormal_biliary_tract | 1.17751404 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.17092133 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.15239603 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.10913348 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.09833483 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.09497605 |
| 59 | MP0000343_altered_response_to | 1.06452677 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.06389264 |
| 61 | MP0005166_decreased_susceptibility_to | 1.05810068 |
| 62 | MP0001542_abnormal_bone_strength | 1.05100436 |
| 63 | MP0001873_stomach_inflammation | 1.03192516 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.02953971 |
| 65 | MP0003878_abnormal_ear_physiology | 1.02953971 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.01706680 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.01258275 |
| 68 | MP0003718_maternal_effect | 1.01095397 |
| 69 | MP0003693_abnormal_embryo_hatching | 0.99265458 |
| 70 | MP0003136_yellow_coat_color | 0.99201470 |
| 71 | MP0001293_anophthalmia | 0.99172350 |
| 72 | MP0000647_abnormal_sebaceous_gland | 0.98982404 |
| 73 | MP0001666_abnormal_nutrient_absorption | 0.98873477 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.96878644 |
| 75 | MP0005332_abnormal_amino_acid | 0.96304052 |
| 76 | MP0003195_calcinosis | 0.96034356 |
| 77 | MP0003315_abnormal_perineum_morphology | 0.95026522 |
| 78 | MP0009764_decreased_sensitivity_to | 0.91800592 |
| 79 | MP0005365_abnormal_bile_salt | 0.90484119 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.90262653 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.90057423 |
| 82 | MP0002163_abnormal_gland_morphology | 0.87380913 |
| 83 | MP0000716_abnormal_immune_system | 0.86371965 |
| 84 | MP0005620_abnormal_muscle_contractility | 0.86296070 |
| 85 | MP0002972_abnormal_cardiac_muscle | 0.86145794 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.85861378 |
| 87 | MP0000566_synostosis | 0.85405672 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.84567288 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.82743575 |
| 90 | MP0000427_abnormal_hair_cycle | 0.81218088 |
| 91 | MP0000858_altered_metastatic_potential | 0.80545590 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.80475893 |
| 93 | MP0003880_abnormal_central_pattern | 0.79494436 |
| 94 | MP0008469_abnormal_protein_level | 0.79214418 |
| 95 | MP0005000_abnormal_immune_tolerance | 0.78886864 |
| 96 | MP0002067_abnormal_sensory_capabilities | 0.78821612 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.78400296 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.78252802 |
| 99 | MP0002938_white_spotting | 0.77734167 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.75773861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.98006323 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.46986736 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.42589039 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.19381090 |
| 5 | Delayed CNS myelination (HP:0002188) | 4.11907759 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.90740568 |
| 7 | Hepatic necrosis (HP:0002605) | 3.77528713 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.75143243 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.75143243 |
| 10 | Increased CSF lactate (HP:0002490) | 3.66035641 |
| 11 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.65963657 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.52571449 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.51183180 |
| 14 | Acute encephalopathy (HP:0006846) | 3.50745827 |
| 15 | Glucose intolerance (HP:0000833) | 3.35245877 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.29139356 |
| 17 | IgG deficiency (HP:0004315) | 3.26460047 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.16037312 |
| 19 | Chronic sinusitis (HP:0011109) | 3.13093488 |
| 20 | Exercise intolerance (HP:0003546) | 3.06601948 |
| 21 | Aplastic anemia (HP:0001915) | 2.99918953 |
| 22 | Congenital, generalized hypertrichosis (HP:0004540) | 2.93833064 |
| 23 | Increased muscle lipid content (HP:0009058) | 2.92772515 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 2.92003941 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.90640003 |
| 26 | Nausea (HP:0002018) | 2.87784631 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.81458577 |
| 28 | Cerebral edema (HP:0002181) | 2.74460611 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.72402788 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71075779 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71075779 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.71075779 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.71075779 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.70708976 |
| 35 | Methylmalonic aciduria (HP:0012120) | 2.70457079 |
| 36 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.69945137 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.67829695 |
| 38 | Diplopia (HP:0000651) | 2.67829695 |
| 39 | Abnormal glucose tolerance (HP:0001952) | 2.62438492 |
| 40 | Down-sloping shoulders (HP:0200021) | 2.60483684 |
| 41 | Recurrent bronchitis (HP:0002837) | 2.58416280 |
| 42 | Palpitations (HP:0001962) | 2.55413307 |
| 43 | 3-Methylglutaconic aciduria (HP:0003535) | 2.54939794 |
| 44 | Increased IgM level (HP:0003496) | 2.52881857 |
| 45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.46281227 |
| 46 | Increased serum lactate (HP:0002151) | 2.45326069 |
| 47 | Lactic acidosis (HP:0003128) | 2.45229731 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.39862428 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39862428 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.38972103 |
| 51 | Prostate neoplasm (HP:0100787) | 2.36953185 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.36079834 |
| 53 | IgM deficiency (HP:0002850) | 2.31900480 |
| 54 | Malnutrition (HP:0004395) | 2.31657547 |
| 55 | Palpebral edema (HP:0100540) | 2.30676776 |
| 56 | Exertional dyspnea (HP:0002875) | 2.30473334 |
| 57 | Torticollis (HP:0000473) | 2.29669017 |
| 58 | Respiratory failure (HP:0002878) | 2.23569467 |
| 59 | Pancytopenia (HP:0001876) | 2.21950572 |
| 60 | Adrenal hypoplasia (HP:0000835) | 2.20971632 |
| 61 | Opisthotonus (HP:0002179) | 2.16969225 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.16076708 |
| 63 | Glycosuria (HP:0003076) | 2.11548316 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.11548316 |
| 65 | Optic disc pallor (HP:0000543) | 2.06324779 |
| 66 | Large for gestational age (HP:0001520) | 2.05201683 |
| 67 | Axonal loss (HP:0003447) | 2.02942826 |
| 68 | Lethargy (HP:0001254) | 2.02197002 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.01777932 |
| 70 | Abnormal spermatogenesis (HP:0008669) | 1.99565344 |
| 71 | Late onset (HP:0003584) | 1.98262258 |
| 72 | Abnormality of T cell number (HP:0011839) | 1.98037999 |
| 73 | Renal cortical cysts (HP:0000803) | 1.97491927 |
| 74 | Skin rash (HP:0000988) | 1.97426854 |
| 75 | T lymphocytopenia (HP:0005403) | 1.97242528 |
| 76 | Depressed nasal tip (HP:0000437) | 1.95014130 |
| 77 | Supernumerary spleens (HP:0009799) | 1.91140564 |
| 78 | Poor speech (HP:0002465) | 1.90761821 |
| 79 | Rhabdomyolysis (HP:0003201) | 1.88101642 |
| 80 | Rough bone trabeculation (HP:0100670) | 1.87850396 |
| 81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.87674354 |
| 82 | Testicular atrophy (HP:0000029) | 1.87650224 |
| 83 | Sparse eyelashes (HP:0000653) | 1.86257808 |
| 84 | Craniofacial dystonia (HP:0012179) | 1.85837342 |
| 85 | Tongue fasciculations (HP:0001308) | 1.85736277 |
| 86 | Hypoproteinemia (HP:0003075) | 1.85566742 |
| 87 | Hypoplasia of the uterus (HP:0000013) | 1.84638325 |
| 88 | Abnormality of vitamin B metabolism (HP:0004340) | 1.81936405 |
| 89 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80229909 |
| 90 | Confusion (HP:0001289) | 1.78773400 |
| 91 | Hypokinesia (HP:0002375) | 1.78111928 |
| 92 | Hyperglycinemia (HP:0002154) | 1.77324652 |
| 93 | Oral leukoplakia (HP:0002745) | 1.73921458 |
| 94 | Cerebral palsy (HP:0100021) | 1.73166656 |
| 95 | Progressive external ophthalmoplegia (HP:0000590) | 1.71838177 |
| 96 | Postural tremor (HP:0002174) | 1.71672455 |
| 97 | IgA deficiency (HP:0002720) | 1.70657458 |
| 98 | Amyloidosis (HP:0011034) | 1.70591468 |
| 99 | Vascular calcification (HP:0004934) | 1.70010583 |
| 100 | Focal dystonia (HP:0004373) | 1.66976148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.47056632 |
| 2 | GRK1 | 3.21315080 |
| 3 | LIMK1 | 3.17961939 |
| 4 | TESK1 | 3.11962050 |
| 5 | KDR | 2.44293640 |
| 6 | TESK2 | 11.5080717 |
| 7 | NME2 | 1.89979749 |
| 8 | TXK | 1.87722535 |
| 9 | STK16 | 1.83756122 |
| 10 | PHKG1 | 1.78759315 |
| 11 | PHKG2 | 1.78759315 |
| 12 | MAP3K12 | 1.69608685 |
| 13 | MST4 | 1.63698733 |
| 14 | MAPKAPK3 | 1.54958642 |
| 15 | SRPK1 | 1.46642150 |
| 16 | DAPK1 | 1.42442144 |
| 17 | BCKDK | 1.40365817 |
| 18 | WNK3 | 1.38477711 |
| 19 | SIK3 | 1.35038441 |
| 20 | EPHA2 | 1.34914442 |
| 21 | BUB1 | 1.26451835 |
| 22 | MAP4K2 | 1.16462931 |
| 23 | SIK2 | 1.15862979 |
| 24 | MYLK | 1.14773351 |
| 25 | VRK1 | 1.14326315 |
| 26 | DYRK2 | 1.12899255 |
| 27 | ADRBK2 | 1.10988692 |
| 28 | ABL2 | 1.05982714 |
| 29 | TLK1 | 1.05504948 |
| 30 | EPHB2 | 1.01878018 |
| 31 | ARAF | 0.98952848 |
| 32 | ZAK | 0.94697801 |
| 33 | MAP3K10 | 0.93961729 |
| 34 | LMTK2 | 0.93110303 |
| 35 | MAP2K7 | 0.85806262 |
| 36 | PIM2 | 0.84797928 |
| 37 | CCNB1 | 0.83948683 |
| 38 | MARK1 | 0.82180271 |
| 39 | ILK | 0.80574810 |
| 40 | ITK | 0.78021071 |
| 41 | NUAK1 | 0.76703562 |
| 42 | RPS6KA4 | 0.73767420 |
| 43 | MAP3K11 | 0.71323918 |
| 44 | PTK2B | 0.68374480 |
| 45 | PDK2 | 0.66694050 |
| 46 | SCYL2 | 0.65297548 |
| 47 | NME1 | 0.59699035 |
| 48 | EIF2AK1 | 0.57452744 |
| 49 | TAF1 | 0.56435878 |
| 50 | DAPK2 | 0.54033757 |
| 51 | CDK19 | 0.52760820 |
| 52 | LRRK2 | 0.48201346 |
| 53 | SYK | 0.47350864 |
| 54 | CSNK1G3 | 0.43342692 |
| 55 | TBK1 | 0.43171773 |
| 56 | PAK4 | 0.42497602 |
| 57 | ADRBK1 | 0.42481110 |
| 58 | PRKCI | 0.41275158 |
| 59 | OBSCN | 0.41103579 |
| 60 | IKBKE | 0.40959767 |
| 61 | MAPK13 | 0.39485496 |
| 62 | CAMK2G | 0.38358545 |
| 63 | CASK | 0.38186587 |
| 64 | MARK3 | 0.37752116 |
| 65 | CDK8 | 0.37072423 |
| 66 | BMPR2 | 0.36945378 |
| 67 | EIF2AK3 | 0.35819993 |
| 68 | AURKA | 0.35324982 |
| 69 | BMPR1B | 0.34867212 |
| 70 | DAPK3 | 0.34028132 |
| 71 | RPS6KA5 | 0.34000925 |
| 72 | GRK5 | 0.31854101 |
| 73 | GSK3A | 0.30063039 |
| 74 | ROCK1 | 0.29437157 |
| 75 | EPHA4 | 0.29006113 |
| 76 | PRKCQ | 0.28808050 |
| 77 | PIK3CA | 0.28247004 |
| 78 | CSNK1G2 | 0.27947150 |
| 79 | LYN | 0.27711785 |
| 80 | PINK1 | 0.26753354 |
| 81 | KIT | 0.26506971 |
| 82 | IKBKB | 0.26187639 |
| 83 | MAP4K1 | 0.25867675 |
| 84 | CAMK2A | 0.25738516 |
| 85 | GRK7 | 0.25430138 |
| 86 | MOS | 0.24603697 |
| 87 | SIK1 | 0.23935499 |
| 88 | CSNK1A1L | 0.23615153 |
| 89 | INSRR | 0.22593656 |
| 90 | STK10 | 0.22374217 |
| 91 | PRKACA | 0.21845370 |
| 92 | IGF1R | 0.21290316 |
| 93 | CLK1 | 0.21066462 |
| 94 | CSK | 0.20558634 |
| 95 | CSNK1G1 | 0.20505238 |
| 96 | CAMK2D | 0.20483467 |
| 97 | CSNK2A1 | 0.19851387 |
| 98 | ERBB4 | 0.19440868 |
| 99 | MUSK | 0.18215447 |
| 100 | FYN | 0.17571567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.45575611 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.16606579 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.75345980 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.70141579 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.57774310 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.56188327 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39949435 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.31946767 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.22275916 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.17231995 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 2.15428805 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08009502 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07669142 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.06895007 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.04565078 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03859974 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.02594596 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95266412 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.93432773 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.88880467 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.88059502 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.70313798 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67247410 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.63908480 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48071291 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47576727 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33552554 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30723810 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.22463526 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.20263172 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18389906 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16672075 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.11675050 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06252928 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04869269 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03247015 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01860746 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00737622 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98394303 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96505826 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94599877 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86996919 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86117544 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85184676 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85151104 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84138317 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82563857 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81464149 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80779153 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77255479 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76339295 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75774809 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.75527065 |
| 54 | Mismatch repair_Homo sapiens_hsa03430 | 0.74223565 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73475583 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73353293 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72039979 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70701137 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66529569 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65371679 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62734014 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.62598234 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.62070834 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61904322 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58982699 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58110115 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56159283 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.55248864 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53976572 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53353275 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52891368 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50333239 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49470844 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48898490 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46929515 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46160641 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44875131 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43116386 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41626747 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.41116335 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38549585 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37792733 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36065221 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34833386 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33871394 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.33828227 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32996242 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.32802784 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31624091 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28125895 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.28006335 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26609178 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26579658 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26323746 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25769885 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22129906 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.19589198 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.18880240 |
| 99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18381793 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17538615 |

